NCT04247893

Brief Summary

Knee osteoarthritis (OA) is one of the most common musculoskeletal disorders in the world. The aim of this project is to evaluate the additional effect of photobiomodulation therapy on the quadriceps muscle and knee joint in a blood flow restriction exercise program for individuals with knee OA. To this end, volunteers will be selected at random, aged between 40 and 65 years with pain in one knee, at least in the last 6 months, diagnosed with unilateral knee OA based on the criteria established by the American College of Rheumatology and radiographic confirmation for grades 2 or 3 of the Kellgren-Lawrence Classification, will be randomized into the following groups: (Exercises with blood flow restriction, n = 20), (Exercises with blood flow restriction + photobiomodulation, n = 20) and Exercises with blood flow restriction + placebo photobiomodulation (n = 20). 12 consecutive weeks of treatment will be carried out, with the volunteers being evaluated before and after, using the following instruments: The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), sit and stand test, Timed up and Go (TUG), numerical scale pain assessment (END), pain-to-pressure threshold (LDP), skin temperature: quadriceps musculature, knee joint and maximum voluntary isometric contraction (MVIC) of the muscles: quadriceps, middle gluteus. For data analysis, normality test will be used to verify the data distribution and statistical test consistent with the appropriate comparisons within and between groups, thus, two factors are considered in the comparisons, time and group. A significance level of 5% will be adopted.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 31, 2020

Status Verified

January 1, 2020

Enrollment Period

Same day

First QC Date

January 27, 2020

Last Update Submit

January 29, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Functional pain

    The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation Knee Osteoarthritis.

    Change from Baseline in The Western Ontario and McMaster Universities Arthritis Index at 12 weeks

  • Stiffness

    The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation Knee Osteoarthritis.

    Time Frame: Change from Baseline in The Western Ontario and McMaster Universities Arthritis Index at 12 weeks

  • Physical functional

    The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation Knee Osteoarthritis.

    Change from Baseline in The Western Ontario and McMaster Universities Arthritis Index at 12 weeks

Secondary Outcomes (5)

  • Intensity of pain

    Change from Baseline in The Numerical rating pain scale at 12 weeks

  • Functional capacity for sitting and standing

    Change from Baseline in The Functional capacity for sitting and standing at 12 weeks

  • Level of pressure pain

    Change from Baseline in ThePressure Pain Threshold at 12 weeks

  • Muscle skin temperature

    Change from Baseline in the muscle skin temperature at 12 weeks

  • Maximum voluntary isometric contraction

    Change from Baseline in the Maximum voluntary isometric contraction at 12 weeks

Study Arms (3)

Exercises with blood flow restriction

ACTIVE COMPARATOR

Exercise: 10 minutes of heating on a treadmill without changing the inclination and adopting a standardized speed; Supine bridge, Supine unilateral bridge, Flexion of the hip with the knee extended, Knee extension, volunteer in sedation; Prone knee flexion; Squat on the wall associated with isometric contraction; Abduction of the hip, lateral rotation and knee extension in lateral decubitus associated with isometric contraction; Abduction, lateral rotation of the hip, slight knee and hip flexion performing abduction with the feet together: associated with isometric contraction; Abduction of the hip in orthostatic associated with isometric contraction.Device: The blood flow restriction in mmHg will be performed using a vascular occlusion training manometer, positioned in the thigh inguinal region and inflated to the point where the auscultatory pulse of the tibial artery is interrupted.

Device: blood flow restriction

Exercises with blood flow restriction + photobiomodulation

EXPERIMENTAL

Exercise: 10 minutes of heating on a treadmill without changing the inclination and adopting a standardized speed; Supine bridge, Supine unilateral bridge, Flexion of the hip with the knee extended, Knee extension, volunteer in sedation; Prone knee flexion; Squat on the wall associated with isometric contraction; Abduction of the hip, lateral rotation and knee extension in lateral decubitus associated with isometric contraction; Abduction, lateral rotation of the hip, slight knee and hip flexion performing abduction with the feet together: associated with isometric contraction; Abduction of the hip in orthostatic associated with isometric contraction.Devices: The blood flow restriction in mmHg will be performed using a vascular occlusion training manometer, positioned in the thigh inguinal region and inflated to the point where the auscultatory pulse of the tibial artery is interrupted.Photobiomodulation a mesh composed of multiple diodes containing 50 Infrared LEDs.

Device: blood flow restrictionDevice: Photobiomodulation

Blood flow restriction exercises + placebo photobiomodulation

PLACEBO COMPARATOR

Exercise: 10 minutes of heating on a treadmill without changing the inclination and adopting a standardized speed; Supine bridge, Supine unilateral bridge, Flexion of the hip with the knee extended, Knee extension, volunteer in sedation; Prone knee flexion; Squat on the wall associated with isometric contraction; Abduction of the hip, lateral rotation and knee extension in lateral decubitus associated with isometric contraction; Abduction, lateral rotation of the hip, slight knee and hip flexion performing abduction with the feet together: associated with isometric contraction; Abduction of the hip in orthostatic associated with isometric contraction.Devices: The blood flow restriction in mmHg will be performed using a vascular occlusion training manometer, positioned in the thigh inguinal region and inflated to the point where the auscultatory pulse of the tibial artery is interrupted. Photobiomodulation turned off with a mesh composed of multiple diodes containing 50 Infrared LEDs.

Device: blood flow restrictionDevice: Placebo photobiomodulation

Interventions

Occlusion training is an exercise approach whereby resistance exercise or aerobic exercise is performed whilst an occlusion cuff is applied to proximal aspect of the muscle.

Blood flow restriction exercises + placebo photobiomodulationExercises with blood flow restrictionExercises with blood flow restriction + photobiomodulation

Photobiomodulation therapy is defined as the utilization of non-ionizing electromagnetic energy to trigger photochemical changes within cellular structures that are receptive to photons.

Exercises with blood flow restriction + photobiomodulation

Placebo photobiomodulation - photobiomodulation device turned off.

Blood flow restriction exercises + placebo photobiomodulation

Eligibility Criteria

Age40 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAs it is a disease more prevalent in women than men and more, understanding the variability in strength and muscle mass, we decided to include only female volunteers.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • knee pain to at least six months and minimum of 4 points in pain scale
  • diagnosis of unilateral knee OA based on criteria established by the American College of Rheumatology and radiographic confirmation for grades 2 or 3 of the Kellgren-Lawrence Classification.

You may not qualify if:

  • Score on the numerical visual analog of knee pain less than 1 or greater than 8;
  • knee trauma;
  • Cognitive impairment;
  • Psychological disorder;
  • Neurological disorder (sensory or motor);
  • Cancer;
  • Diabetes any acute adverse health condition;
  • Signs of hip OA;
  • Sings cardiopulmonary disease that could prevent exercise and use of a walking assist device.
  • Have undergone any form of treatment involving: physiotherapy, intra-articular corticosteroids, anti-inflammatories or chondroprotectors in the last year.
  • If the size of the circumference of the thigh and knee does not allow the proper positioning of the photobiomodulation mesh.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nove de Julho

São Paulo, 01504-001, Brazil

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Blood Flow Restriction TherapyLow-Level Light Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesLaser TherapyPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor.

Study Record Dates

First Submitted

January 27, 2020

First Posted

January 30, 2020

Study Start

November 1, 2020

Primary Completion

November 1, 2020

Study Completion

December 1, 2022

Last Updated

January 31, 2020

Record last verified: 2020-01

Locations